The LIPT1 gene helps switch on several enzymes that let cells turn food into usable energy. This gene plays an important role in energy production, especially in tissues with high energy needs such as the brain and muscles. If both copies of the LIPT1 gene do not work well, the body may build up lactic acid and struggle to support normal growth and development, which can lead to low muscle tone, feeding problems, developmental delay, and seizures. LIPT1 is mainly known in rare metabolic medicine rather than popular culture.
What is a gene?
Genes are stretches of DNA that carry instructions your cells use to make molecules or regulate processes in the body. Some genes hold the information needed to produce proteins, the parts of cells that do much of the work. Others mainly direct when certain processes happen, where they take place, and how strongly they operate. Taken together, genes affect how the body develops and works, and they can also shape how you respond to food, stress, or medications. To explore this topic in greater depth, you can find more in the LearnHub.
Overview
LIPT1Gene function
What if the gene works
The LIPT1 gene helps mitochondria, your cells’ energy centers, attach a small helper molecule to enzymes that turn food into energy and process certain amino acids.
Risk
What if the gene does not work
Variants in the LIPT1 gene can disrupt energy production and often lead to lactic acidosis, feeding difficulty, seizures, and developmental delay. Effects can range from milder to more severe, influencing when symptoms begin and how widely organs are affected.
Treatment
What does that mean for your treatment
At present, no LIPT1-specific treatment or management approach is established in clinical guidelines for people with a pathogenic or loss-of-function variant in the LIPT1 gene.
Conditions associated with LIPT1
Gene function
What if the gene works
Deep inside mitochondria, the parts of cells that make most of your energy, your cells use the LIPT1 gene to prepare key enzymes for work. Its protein helps attach lipoic acid, a small helper molecule, to these enzymes. This is part of how the LIPT1 gene helps your mitochondria use food for energy in a steady way.
The LIPT1 gene helps attach lipoic acid, a small helper molecule, to selected enzymes in mitochondria. This attachment allows those enzymes to work properly.
By preparing these enzymes, the LIPT1 gene supports how cells move energy from food into the main energy making pathways. This helps your body produce a steady supply of cellular energy.
The LIPT1 gene also supports enzyme systems that process certain amino acids, the building blocks of protein. This helps cells manage several small fuel molecules during everyday metabolism.
What is a variant?
Within a gene, a genetic variant is a small change in its DNA sequence. Variants are common and are one reason people differ in features such as appearance, metabolism, and how the body responds to environmental influences. A large number cause no noticeable changes and only reflect normal genetic variation. Sometimes, however, a variant affects a gene’s function more strongly and can contribute to or cause a genetic condition.
Genetic variants
What if the gene does not work
Variants in the LIPT1 gene can reduce or block the cell’s ability to attach lipoic acid, a small helper molecule, to key mitochondrial enzymes. This is central to how LIPT1 variants affect mitochondrial enzyme activity, because the altered protein may be unstable, fold poorly, or transfer the helper molecule less effectively. Milder variants may leave some activity, while more severe variants can cause a larger loss of function and may be linked to earlier or more pronounced disease linked to the LIPT1 gene.
How variants are linked to conditions
Current evidence shows that pathogenic LIPT1 gene variants cause LIPT1 deficiency, a rare inherited metabolic condition. People with this confirmed genetic diagnosis often develop symptoms in infancy or early childhood, including high acid levels in the blood, feeding problems, seizures, and developmental delay. Severity can vary from one person to another.
A variant is not necessarily a diagnosis
Genetic variants are a normal feature of human biology and are common throughout the general population. Most do not have a direct effect on health and simply reflect natural human diversity. For many genes, carrying a variant tied to a condition indicates a possible association rather than a definite diagnosis, especially when multiple genes and environmental factors play a role. In some situations, though, a single well-characterized variant in a specific gene is enough to confirm a diagnosis.
Are there things that can increase or change my risk?
There is no broadly confirmed evidence that specific lifestyle or environmental factors change health risk related to the LIPT1 gene. For families with a known LIPT1 change, risk is mainly shaped by whether someone inherited disease-causing changes in both copies of the gene, and a doctor or genetic counselor can help explain personal risk.
Inheritance of LIPT1 variants
Variants in the LIPT1 gene are inherited in an autosomal recessive pattern. This means a child usually inherits one altered copy from each parent, and both parents are typically carriers without symptoms. When both parents carry a LIPT1 gene variant, each pregnancy has a 25% chance of resulting in a child with the condition, a 50% chance of producing a carrier child, and a 25% chance of producing a child without the variant. In families affected by lipoyltransferase 1 deficiency, this pattern explains the inheritance of the LIPT1 gene variants.
What does my LIPT1 result mean for my family?
For families with a disease-causing LIPT1 result, this condition is usually passed down in a recessive pattern, which means parents are often healthy carriers. Brothers and sisters may also be affected or may be carriers, and other close relatives could be carriers as well. This can matter for family planning and for relatives who want to understand their own chance of carrying the same gene change.
Genetic information
Genetic testing
How you find out about variants
To look for changes linked to a LIPT1-related condition, doctors use LIPT1 genetic testing on a blood sample, saliva sample, or cheek swab. A lab reads the LIPT1 gene to check for variants and may compare both gene copies to see whether the results support a diagnosis or show that you carry one variant.
When should I consider getting a genetic test?
Testing for the LIPT1 gene may be worth considering when a baby or child has signs of a rare inherited energy condition, such as dangerously high acid levels in the blood, low muscle tone, feeding problems, seizures, or developmental delay. It can also help when there is a family history of this condition or a known LIPT1 variant in the family.
A genetic result is only one part of your health story
A genetic result may provide valuable insight, but how much it can tell you varies by the condition and the type of variant involved. Over time, many factors, including lifestyle, environment, age, and medical history, also shape how the body functions. In some conditions, especially those influenced by many genes, genetic information offers context rather than certainty and is most useful when considered alongside other parts of care. In other situations, a genetic result may offer a clear answer. In areas like medication response, genetic results can help put individual experiences into perspective.
Pharmacogenetics
How variants shape your response to medicine
Genetic variation can affect how people respond to medicines. Two people can take the same treatment and have different results because their bodies may absorb, break down, or respond to a drug in different ways. These inherited differences are common and can influence how well a medicine works or how sensitive someone is to side effects.
What is Pharmacogenetics?
Pharmacogenetics examines how genetic differences can affect a person’s response to medications. It looks at relationships between genes and drugs to help explain why the same treatment may work differently from one person to another. For many medicines, genes influence both how strongly a drug works and how the body processes it. This information can support more informed and more individualized treatment decisions. To explore this subject in greater detail, you can learn more in the LearnHub.
Drugs influenced by the LIPT1 gene
When should I seek medical advice?
There is not yet a broadly confirmed role for this gene in guiding how medicines are chosen or how well they work, so any concerns about treatments, side effects, or new symptoms are best discussed with your doctor.
History
In recent decades, awareness of the LIPT1 gene’s role grew through research on rare inherited metabolic conditions. Early laboratory work on lipoic acid pathways in cells and animal models helped scientists recognize that a human gene was needed for this same process. From these first observations, research expanded steadily, and LIPT1 was identified as part of the group of genes involved in mitochondrial energy pathways. Clinical reports in the 2010s then linked harmful variants in the LIPT1 gene to an inherited condition affecting energy use, especially in infancy and childhood. These findings helped connect earlier biochemical clues with a specific genetic cause. Since then, the gene has mainly been studied in rare disease genetics rather than in public awareness campaigns.